查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370515

静脉 (IV) 布洛芬市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Intravenous (IV) Ibuprofen Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

抽象的

市场概况：

2022年，全球静脉注射（IV）布洛芬市场规模达63亿美元。展望未来，IMARC集团预计到2028年市场规模将达到102亿美元，2023-2028年复合年增长率（CAGR）为7.78% 。

布洛芬属于非类固醇类抗发炎药 (NSAID)，用于治疗发炎、疼痛和发烧。它抑制合成前列腺素 (PG) 所需的环氧合酶 COZ-1 和 COX-2。静脉注射 (IV) 布洛芬可单独使用或与其他药物一起使用，以缓解轻度至重度不适。它被直接注射到静脉中，以阻止身体产生某些引起发炎的天然物质。它具有出色的安全性，有助于减少麻醉镇痛需求并降低疼痛程度。静脉注射布洛芬也有助于改善疼痛控制并减少骨科和腹部手术中阿片类药物的使用以及发烧。

静脉（IV）布洛芬市场趋势：

全球范围内老年人口的稳定增长以及关节炎、心血管疾病 (CVD) 和癌症患病率的不断上升正在为市场创造积极的前景。与此一致的是，用于管理和治疗发炎性疾病、类风湿性疾病、轻度至中度疼痛、发烧、经痛和骨关节炎的产品的广泛采用有利于市场成长。此外，繁忙的工作日程和不健康的生活方式，以及随之而来的体力活动和适当营养的减少，导致慢性病的发病率上升，这是另一个促进生长的因素。除此之外，儿科治疗轻度发烧、牙痛、胃肠道疼痛和动脉导管的产品使用量不断增加，也推动了市场成长。此外，静脉注射布洛芬用于缓解肌肉或风湿疼痛、背痛、神经痛、扭伤、拉伤、运动伤害和肌肉骨骼疾病，这促进了市场成长。此外，骨科患者在膝关节或髋关节置换手术后对静脉注射布洛芬的需求不断增加，以减轻疼痛和吗啡的使用，这对市场成长产生了积极影响。其他因素，包括医疗保健基础设施的显着改善、个人健康意识的增强以及消费者支出能力的提高，预计将推动市场成长。

本报告回答的关键问题

  • 2022年全球静脉（IV）布洛芬市场规模？
  • 2023-2028年全球静脉（IV）布洛芬市场的预期成长率是多少？
  • 推动全球静脉（IV）布洛芬市场的关键因素是什么？
  • COVID-19 对全球静脉 (IV) 布洛芬市场有何影响？
  • 根据适应症，全球静脉 (IV) 布洛芬市场的细分如何？
  • 按年龄组别划分，全球静脉 (IV) 布洛芬市场的细分如何？
  • 全球静脉（IV）布洛芬市场的主要区域有哪些？
  • 全球静脉 (IV) 布洛芬市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球静脉 (IV) 布洛芬市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品剂量分類的市场

  • 100 毫克剂量
    • 市场走向
    • 市场预测
  • 200 毫克剂量
    • 市场走向
    • 市场预测
  • 400 毫克剂量
    • 市场走向
    • 市场预测
  • 800 毫克剂量
    • 市场走向
    • 市场预测

第 7 章：按迹象分類的市场

  • 疼痛/炎症
    • 市场走向
    • 市场预测
  • 发烧
    • 市场走向
    • 市场预测

第 8 章：按年龄组别分類的市场区隔

  • 儿科
    • 市场走向
    • 市场预测
  • 成年人
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Cumberland Pharmaceuticals Inc.
    • Hyloris Pharmaceuticals SA
    • Recordati Rare Diseases Inc.
    • VALMOR Laboratories CA
    • Xgen Pharmaceuticals Djb Inc.
Product Code: SR112023A6440

Abstract

Market Overview:

The global intravenous (IV) ibuprofen market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 7.78% during 2023-2028.

Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.

Intravenous (IV) Ibuprofen Market Trends:

The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous (IV) ibuprofen market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product dose, indication and age group.

Breakup by Product Dose:

100 Mg Dose

200 Mg Dose

400 Mg Dose

800 Mg Dose

Breakup by Indication:

Pain/Inflammatory

Fever

Breakup by Age Group:

Pediatrics

Adults

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global Intravenous (IV) ibuprofen market in 2022?
  • 2. What is the expected growth rate of the global Intravenous (IV) ibuprofen market during 2023-2028?
  • 3. What are the key factors driving the global Intravenous (IV) ibuprofen market?
  • 4. What has been the impact of COVID-19 on the global Intravenous (IV) ibuprofen market?
  • 5. What is the breakup of the global Intravenous (IV) ibuprofen market based on the indication?
  • 6. What is the breakup of the global Intravenous (IV) ibuprofen market based on the age group?
  • 7. What are the key regions in the global Intravenous (IV) ibuprofen market?
  • 8. Who are the key players/companies in the global Intravenous (IV) ibuprofen market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Ibuprofen Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Dose

  • 6.1 100 Mg Dose
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 200 Mg Dose
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 400 Mg Dose
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 800 Mg Dose
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Pain/Inflammatory
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fever
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 Pediatrics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Adults
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Cumberland Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hyloris Pharmaceuticals SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Recordati Rare Diseases Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 VALMOR Laboratories CA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Xgen Pharmaceuticals Djb Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Ibuprofen Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2022
  • Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2022
  • Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
  • Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
  • Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million US$), 2023-2028
  • Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
  • Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
  • Table 7: Global: Intravenous Ibuprofen Market: Key Players